Oevau Technologies Inc entered the industry of Patent Medicines in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 424210, which describes it as a Patent Medicines. For further clarification, the SIC classifies this business under the code 5122 and described it as a Patent Medicines. The business provides service to the B2B market.
To acquire more information, please contact Richard Gorman by calling No number given during business hours. You can also write to the business’ Single Location at 320 North Magnolia Avenue # A6, Orlando, Florida FL 32801. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Oevau Technologies Inc |
| Representative: | Richard Gorman |
| Place of Business: | 320 North Magnolia Avenue # A6, Orlando, FL 32801 |
| Contact Number: | No number given |
| Type of Service: | Patent Medicines |
| SIC Number: | 5122 |
| NAICS Number: | 424210 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2003 |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Oevau Technologies Inc is a company operating from Orange, Florida providing professional Patent Medicines and relevant B2B variables. It was founded in 2003 and registered with the SIC code 5122 as Patent Medicines, and with the NAICS code 424210 as Patent Medicines.
With a current employee count of 1 to 4, Oevau Technologies Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Richard Gorman at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 320 North Magnolia Avenue # A6 in Orlando, Florida 32801 and can be engaged online through the company website at , the company Twitter , and Facebook page .